Study
Taurine supplementation shows promise for metabolic health and aging: comprehensive review
A detailed review from TU Braunschweig and University of Sao Paulo maps taurine's role in antioxidant defense, anti-inflammatory signaling, calcium regulation, and metabolic health, with promising but early human data.
Summary Does taurine really improve health or slow aging? Show / hide ↓
Researchers reviewed earlier studies on taurine, a substance the body makes naturally and also gets from some foods. They examined possible effects on inflammation, meaning the body’s response to damage, antioxidant defense, which helps limit cell damage, and mitochondrial function, how cells’ energy makers work. Earlier human studies suggested possible benefits for metabolism and age-related health, but the results were limited and the review did not test any new participants. Mouse studies found that taurine supplements extended lifespan by 10% to 12%, but those findings do not directly apply to humans. Another human analysis did not find that taurine consistently declined with age.
What this means for you: This review is not proof that taurine supplements slow human aging or prevent disease. There is not enough evidence to recommend buying taurine for longevity, especially because doses and clear benefits remain uncertain.
early evidenceResearchers from Technische Universität Braunschweig and the University of São Paulo reviewed taurine's molecular functions and supplementation outcomes in metabolism, inflammation, and aging. Taurine is the most abundant free amino acid in many tissues and functions as a non-proteinogenic beta-amino acid. The review describes taurine's roles in antioxidant defense, anti-inflammatory signaling, calcium homeostasis, and mitochondrial function. Supplementation showed promising outcomes in human studies, particularly in precision nutrition and prevention of metabolic and age-related diseases. This review aligns with the 2023 Science study by Singh et al. that linked taurine deficiency to aging and showed 10 to 12 percent lifespan extension in supplemented mice. However, a 2025 NIH study concluded that taurine is unlikely to be a good aging biomarker because it did not longitudinally decline with age in human data. The current review does not resolve this discrepancy but adds mechanistic depth to taurine's multiple targets. No specific dose recommendations or effect sizes from individual human trials are provided in the review abstract.
Taurine supplementation has shown promising outcomes in human studies, with emerging relevance in precision nutrition and prevention of age-related diseases.
The NIH 2025 finding that taurine does not decline with age in humans contradicts the narrative that taurine supplementation replenishes an age-related deficit. The review is narrative, not systematic, and does not provide pooled effect sizes or meta-analytic statistics. Human trial data remains limited compared to the volume of animal evidence.
Cited by
1 encyclopedia entries reference this study.